CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 97 enrolled
Drug / intervention
Prednisolone 1% +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00981435
NCT00981435Phase 4Completed
CompareCT.gov

Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT

Stanford University·interventional·Posted Sep 22, 2009·Updated Aug 7, 2019

In Brief

A Phase 4 clinical trial evaluating Prednisolone 1%, Ketorolac, and 1 other intervention for Glaucoma. Completed, enrolled 97 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
CollaboratorsBascom Palmer Eye Institute, University of Pittsburgh Medical Center

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 22, 2009
Enrollment StartSep 1, 2009
Primary CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 16.8 years ago

Interventions

Prednisolone 1%drug

Prednisolone 1% to lasered eye 4 times/day for 4.5 days

Ketorolacdrug

Ketorolac 0.5% to lasered eye 4 times/day for 4.5 days

Artificial Tearsdrug

Artificial saline tears to lasered eye 4 times/day for 4.5 days